Hims & Hers Health GAAP EPS of $0.32 beats by $0.27, revenue of $401.6M beats by $18.83M

seekingalpha
05 Nov 2024
  • Hims & Hers Health press release (NYSE:HIMS): Q3 GAAP EPS of $0.32 beats by $0.27.
  • Revenue of $401.6M (+77.2% Y/Y) beats by $18.83M.
  • Hims & Hers is providing the following guidance:

  • For the fourth quarter 2024, the company expects:

  • Revenue of $465 million to $470 million vs $421.11M consensus

  • Adjusted EBITDA of $50 million to $55 million, reflecting an Adjusted EBITDA margin of 11% to 12%.

  • For the full year 2024, expects:

  • Revenue of $1.460 billion to $1.465 billion vs $1.40B consensus

  • Adjusted EBITDA of $173 million to $178 million, reflecting an Adjusted EBITDA margin of 12%.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10